The therapeutic effect of ksp inhibitors in preclinical models of cholangiocarcinoma

HIGHLIGHTS

  • who: Yuanyuan Shi from the In vitro cell culture Human CCA cell lines (HCCC-9810, RBE, CCLP1, TFK1, SK-CHA-1, MZ-CHA-1, and CC143476) were used for in vitro studiesHCCC-9810, RBE, and , cells were obtained from the Shanghai Cell Bank of the Chinese Academy of Sciences, China have published the research: The therapeutic effect of KSP inhibitors in preclinical models of cholangiocarcinoma, in the Journal: (JOURNAL) of 16/01/2022
  • what: The authors focus on the mitotic inhibitors, especially the highly selective inhibitor of kinesin spindle protein (KSP, also known as Eg5 . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?